Healthcare Analyst Stanton, along with a key opinion leader discuss the impact of an ADHERE trial result on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) treatment on an Analyst/Industry conference call to be held on August 9 at 6 pm. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSLLY:
- Jefferies healthcare analyst holds an analyst/industry conference call
- CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
- CSL says first patient receives FDA-approved HEMGENIX in U.S.
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue